Literature DB >> 24514919

Transient aphasia: a rare complication of head-up tilt test.

Weihong Chu1, Cheng Wang, Ping Lin, Fang Li, Lijia Wu, Zhenwu Xie.   

Abstract

Head-up tilt test (HUT) is widely used as a diagnostic tool. It reproduces vasovagal attacks in many susceptible patients. Although it is known to be safe and well tolerated, it is a procedure with potential neurologic complications. We observed that it could cause transient aphasia in some patients. To explore clinical characteristics and possible pathogenesis of aphasia induced by HUT, we reviewed the data of patients undergoing HUT in our hospital. 13 patients experienced transient aphasia in 3,488 cases. According to the hemodynamic changes, the incidence in vasodepressor, mixed, cardioinhibition and the negative response were 6.67, 5.52, 0 and 1.14 ‰ orderly, and not significantly different among the groups. It had significant difference between the positive response and the negative response and between vasodepressor and the negative response (both p < 0.05). The incidence in adults was significantly higher than that in children (<18 years) (p < 0.01), but not different between female and male. The average onset time was 11.33 ± 6.66 min (range 4-17 min) during baseline HUT or 4.90 ± 2.69 min (range 2-10 min) during sublingual nitroglycerin-provocated HUT. The duration was 3-60 min, except for one who was completely relieved of the disorder 4 h later. In conclusions, there is a risk of provoking transient aphasia during HUT. It reminds that performer should alert the possibility of transient aphasia during the test, especially when the patient is an adult and has a positive response.

Entities:  

Mesh:

Year:  2014        PMID: 24514919     DOI: 10.1007/s10072-014-1664-1

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  25 in total

Review 1.  Cerebral autoregulation and syncope.

Authors:  Antonio Franco Folino
Journal:  Prog Cardiovasc Dis       Date:  2007 Jul-Aug       Impact factor: 8.194

2.  Lithium toxicity presenting as transient transcortical motor aphasia: a case report.

Authors:  Rachel B Katz; Clifford D Packer
Journal:  Psychosomatics       Date:  2013-09-03       Impact factor: 2.386

3.  Expressive aphasia: an isolated and reversible complication of cerebral malaria in a child.

Authors:  B Maini; R Narayan; A K Bhardwaj; P D Sharma
Journal:  J Vector Borne Dis       Date:  2012-06       Impact factor: 1.688

4.  Comparison of diagnostic accuracy of sublingual nitroglycerin test and low-dose isoproterenol test in patients with unexplained syncope.

Authors:  A Raviele; F Giada; M Brignole; C Menozzi; E Marangoni; G F Manzillo; P Alboni
Journal:  Am J Cardiol       Date:  2000-05-15       Impact factor: 2.778

5.  Piracetam improves activated blood flow and facilitates rehabilitation of poststroke aphasic patients.

Authors:  J Kessler; A Thiel; H Karbe; W D Heiss
Journal:  Stroke       Date:  2000-09       Impact factor: 7.914

6.  Cerebral autoregulatory responses to head-up tilt in normal subjects and patients with recurrent vasovagal syncope.

Authors:  B J Carey; B N Manktelow; R B Panerai; J F Potter
Journal:  Circulation       Date:  2001-08-21       Impact factor: 29.690

7.  Psychogenic stuttering and other acquired nonorganic speech and language abnormalities.

Authors:  Laurence M Binder; Jack Spector; James R Youngjohn
Journal:  Arch Clin Neuropsychol       Date:  2012-07-11       Impact factor: 2.813

8.  Amnesia for loss of consciousness is common in vasovagal syncope.

Authors:  Clodagh O'Dwyer; Kathleen Bennett; Yvonne Langan; Chie Wei Fan; Rose Anne Kenny
Journal:  Europace       Date:  2011-03-23       Impact factor: 5.214

9.  Head-up tilting is a useful provocative test for psychogenic non-epileptic seizures.

Authors:  A Zaidi; S Crampton; P Clough; A Fitzpatrick; B Scheepers
Journal:  Seizure       Date:  1999-09       Impact factor: 3.184

10.  Cerebral vasoconstriction during head-upright tilt-induced vasovagal syncope. A paradoxic and unexpected response.

Authors:  B P Grubb; G Gerard; K Roush; P Temesy-Armos; P Montford; L Elliott; H Hahn; P Brewster
Journal:  Circulation       Date:  1991-09       Impact factor: 29.690

View more
  6 in total

1.  Oral rehydration salts: an effective choice for the treatment of children with vasovagal syncope.

Authors:  Weihong Chu; Cheng Wang; Lijia Wu; Ping Lin; Fang Li; Runmei Zou
Journal:  Pediatr Cardiol       Date:  2015-01-11       Impact factor: 1.655

2.  Neurally mediated syncope diagnosis based on adenylate cyclase activity in Japanese patients.

Authors:  Tomoyoshi Komiyama; Eiichiro Nagata; Tadashi Hashida; Susumu Sakama; Kengo Ayabe; Hiroshi Kamiguchi; Ayumi Sasaki; Koichiro Yoshioka; Hiroyuki Kobayashi
Journal:  PLoS One       Date:  2019-04-18       Impact factor: 3.240

Review 3.  Research progress on the predictive value of electrocardiographic indicators in the diagnosis and prognosis of children with vasovagal syncope.

Authors:  Ting Zhao; Shuo Wang; Miao Wang; Hong Cai; Yuwen Wang; Yi Xu; Runmei Zou; Cheng Wang
Journal:  Front Cardiovasc Med       Date:  2022-07-22

Review 4.  Biomarkers and Hemodynamic Parameters in the Diagnosis and Treatment of Children with Postural Tachycardia Syndrome and Vasovagal Syncope.

Authors:  Wenjie Cheng; Jiaqi Wang; Jing Lin
Journal:  Int J Environ Res Public Health       Date:  2022-06-07       Impact factor: 4.614

5.  Diagnosis and prevention of the vasodepressor type of neurally mediated syncope in Japanese patients.

Authors:  Misaki Hasegawa; Tomoyoshi Komiyama; Kengo Ayabe; Susumu Sakama; Tetsuri Sakai; Kyong Hee Lee; Masahiro Morise; Atsuhiko Yagishita; Mari Amino; Ayumi Sasaki; Eiichiro Nagata; Hiroyuki Kobayashi; Koichiro Yoshioka; Yuji Ikari
Journal:  PLoS One       Date:  2021-06-25       Impact factor: 3.240

6.  Diagnostic and prognostic value of T-wave amplitude difference between supine and orthostatic electrocardiogram in children and adolescents with postural orthostatic tachycardia syndrome.

Authors:  Yuwen Wang; Yi Xu; Fang Li; Ping Lin; Juan Zhang; Runmei Zou; Cheng Wang
Journal:  Ann Noninvasive Electrocardiol       Date:  2020-02-29       Impact factor: 1.468

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.